CN1298713C - 5-取代异苯并呋喃的制备方法 - Google Patents
5-取代异苯并呋喃的制备方法 Download PDFInfo
- Publication number
- CN1298713C CN1298713C CNB028183231A CN02818323A CN1298713C CN 1298713 C CN1298713 C CN 1298713C CN B028183231 A CNB028183231 A CN B028183231A CN 02818323 A CN02818323 A CN 02818323A CN 1298713 C CN1298713 C CN 1298713C
- Authority
- CN
- China
- Prior art keywords
- formula
- group
- citalopram
- trityl
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C251/48—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01830517A EP1281707B1 (en) | 2001-08-02 | 2001-08-02 | Process for the preparation of 5-subtituted isobenzofurans |
| EP01830517.7 | 2001-08-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1555370A CN1555370A (zh) | 2004-12-15 |
| CN1298713C true CN1298713C (zh) | 2007-02-07 |
Family
ID=8184643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB028183231A Expired - Fee Related CN1298713C (zh) | 2001-08-02 | 2002-07-29 | 5-取代异苯并呋喃的制备方法 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7166729B2 (enExample) |
| EP (1) | EP1281707B1 (enExample) |
| JP (1) | JP2005501056A (enExample) |
| KR (1) | KR20040043176A (enExample) |
| CN (1) | CN1298713C (enExample) |
| AR (1) | AR036212A1 (enExample) |
| AT (1) | ATE286037T1 (enExample) |
| AU (1) | AU2002325385B2 (enExample) |
| BG (1) | BG108554A (enExample) |
| BR (1) | BR0211858A (enExample) |
| CA (1) | CA2456004A1 (enExample) |
| DE (1) | DE60108105T2 (enExample) |
| DK (1) | DK1281707T3 (enExample) |
| ES (1) | ES2234797T3 (enExample) |
| HU (1) | HUP0401166A3 (enExample) |
| MX (1) | MXPA04001030A (enExample) |
| PL (1) | PL368320A1 (enExample) |
| PT (1) | PT1281707E (enExample) |
| RO (1) | RO122147B1 (enExample) |
| TW (1) | TWI225055B (enExample) |
| WO (1) | WO2003011846A2 (enExample) |
| ZA (1) | ZA200400841B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IS7239A (is) * | 2001-12-14 | 2004-04-29 | H. Lundbeck A/S | Aðferð til framleiðslu á essítalóprami |
| WO2004026855A1 (en) * | 2002-09-20 | 2004-04-01 | H. Lundbeck A/S | Method for manufacture of dihydroisobenzofuran derivatives |
| GB0601286D0 (en) * | 2006-01-23 | 2006-03-01 | Sandoz Ag | Asymmetric synthesis |
| EP2227233B1 (en) | 2007-11-30 | 2013-02-13 | Newlink Genetics | Ido inhibitors |
| CN106632182A (zh) * | 2016-12-07 | 2017-05-10 | 万全万特制药(厦门)有限公司 | 草酸艾司西酞普兰脱甲基杂质的制备方法 |
| DE112019006382T8 (de) * | 2018-12-22 | 2021-12-09 | Malladi Drugs And Pharmaceuticals Ltd. | NEUES VERFAHREN ZUR HERSTELLUNG VONR-PHENYLACETYLCARBINOL UND β-AMINOALKOHOLEN |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0171943A1 (en) * | 1984-08-06 | 1986-02-19 | H. Lundbeck A/S | Novel intermediate and method for its preparation |
| US4943590A (en) * | 1988-06-14 | 1990-07-24 | H. Lundbeck A/S | Pharmaceutically useful (+)-1-(3-dimethylaminopropyl)-1-(4'-fluorophenyl)-1,3-dihydrosobenzofuran-5-carbonitrile and non-toxic acid addition salts thereof |
| WO1998019513A2 (en) * | 1997-07-08 | 1998-05-14 | H. Lundbeck A/S | Method for the preparation of citalopram |
| WO1999030548A2 (en) * | 1999-04-14 | 1999-06-24 | H. Lundbeck A/S | Method for the preparation of citalopram |
| WO2001002383A2 (en) * | 1999-07-06 | 2001-01-11 | Lundbeck Pharmaceuticals Italy S.P.A. | Process for the synthesis of citalopram |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IES20010143A2 (en) * | 2000-02-24 | 2001-07-25 | Lundbeck & Co As H | Method for the preparation of citalopram |
| IT1319686B1 (it) * | 2000-12-12 | 2003-10-23 | C D Farmasint S R L | Procedimento di preparazione di citalopram. |
-
2001
- 2001-08-02 PT PT01830517T patent/PT1281707E/pt unknown
- 2001-08-02 DK DK01830517T patent/DK1281707T3/da active
- 2001-08-02 EP EP01830517A patent/EP1281707B1/en not_active Expired - Lifetime
- 2001-08-02 AT AT01830517T patent/ATE286037T1/de not_active IP Right Cessation
- 2001-08-02 DE DE60108105T patent/DE60108105T2/de not_active Expired - Fee Related
- 2001-08-02 ES ES01830517T patent/ES2234797T3/es not_active Expired - Lifetime
-
2002
- 2002-07-29 KR KR10-2004-7001616A patent/KR20040043176A/ko not_active Ceased
- 2002-07-29 HU HU0401166A patent/HUP0401166A3/hu unknown
- 2002-07-29 MX MXPA04001030A patent/MXPA04001030A/es active IP Right Grant
- 2002-07-29 PL PL02368320A patent/PL368320A1/xx not_active Application Discontinuation
- 2002-07-29 CA CA002456004A patent/CA2456004A1/en not_active Abandoned
- 2002-07-29 RO ROA200400084A patent/RO122147B1/ro unknown
- 2002-07-29 AU AU2002325385A patent/AU2002325385B2/en not_active Ceased
- 2002-07-29 WO PCT/EP2002/008550 patent/WO2003011846A2/en not_active Ceased
- 2002-07-29 JP JP2003517038A patent/JP2005501056A/ja active Pending
- 2002-07-29 CN CNB028183231A patent/CN1298713C/zh not_active Expired - Fee Related
- 2002-07-29 BR BR0211858-0A patent/BR0211858A/pt not_active IP Right Cessation
- 2002-07-31 TW TW091117176A patent/TWI225055B/zh active
- 2002-08-02 AR ARP020102955A patent/AR036212A1/es unknown
-
2004
- 2004-01-30 BG BG108554A patent/BG108554A/bg unknown
- 2004-01-31 US US10/776,625 patent/US7166729B2/en not_active Expired - Fee Related
- 2004-02-02 ZA ZA200400841A patent/ZA200400841B/en unknown
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0171943A1 (en) * | 1984-08-06 | 1986-02-19 | H. Lundbeck A/S | Novel intermediate and method for its preparation |
| US4943590A (en) * | 1988-06-14 | 1990-07-24 | H. Lundbeck A/S | Pharmaceutically useful (+)-1-(3-dimethylaminopropyl)-1-(4'-fluorophenyl)-1,3-dihydrosobenzofuran-5-carbonitrile and non-toxic acid addition salts thereof |
| WO1998019513A2 (en) * | 1997-07-08 | 1998-05-14 | H. Lundbeck A/S | Method for the preparation of citalopram |
| WO1999030548A2 (en) * | 1999-04-14 | 1999-06-24 | H. Lundbeck A/S | Method for the preparation of citalopram |
| WO2001002383A2 (en) * | 1999-07-06 | 2001-01-11 | Lundbeck Pharmaceuticals Italy S.P.A. | Process for the synthesis of citalopram |
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200400841B (en) | 2005-02-02 |
| KR20040043176A (ko) | 2004-05-22 |
| BR0211858A (pt) | 2004-09-21 |
| TWI225055B (en) | 2004-12-11 |
| DE60108105D1 (de) | 2005-02-03 |
| US7166729B2 (en) | 2007-01-23 |
| HUP0401166A3 (en) | 2007-05-29 |
| DE60108105T2 (de) | 2005-12-08 |
| CN1555370A (zh) | 2004-12-15 |
| HK1070357A1 (zh) | 2005-06-17 |
| PT1281707E (pt) | 2005-04-29 |
| AU2002325385B8 (en) | 2003-02-17 |
| ATE286037T1 (de) | 2005-01-15 |
| US20040230065A1 (en) | 2004-11-18 |
| AR036212A1 (es) | 2004-08-18 |
| WO2003011846A2 (en) | 2003-02-13 |
| CA2456004A1 (en) | 2003-02-13 |
| HUP0401166A2 (hu) | 2004-09-28 |
| PL368320A1 (en) | 2005-03-21 |
| BG108554A (bg) | 2005-03-31 |
| RO122147B1 (ro) | 2009-01-30 |
| EP1281707A1 (en) | 2003-02-05 |
| WO2003011846A3 (en) | 2003-11-27 |
| JP2005501056A (ja) | 2005-01-13 |
| EP1281707B1 (en) | 2004-12-29 |
| DK1281707T3 (da) | 2005-05-02 |
| MXPA04001030A (es) | 2004-12-03 |
| AU2002325385B2 (en) | 2007-07-05 |
| WO2003011846B1 (en) | 2003-12-24 |
| ES2234797T3 (es) | 2005-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1055466C (zh) | 制备1,2-苯并异噻唑-3-酮的方法 | |
| JP2014505097A (ja) | アジルサルタンメドキソミルの改良製造方法 | |
| CN1298713C (zh) | 5-取代异苯并呋喃的制备方法 | |
| CN1066728C (zh) | 生产环氧化物的方法 | |
| CN1118783A (zh) | 新的吡啶并[3,2-b][1,5]苯并硫代吖庚因的制备方法 | |
| EP2809665A1 (en) | Process for the preparation of vilazodone or its pharmaceutically acceptable salts | |
| CN1301259A (zh) | 用作抗糖尿病剂的α-(1-哌嗪基)乙酰氨基芳烃羧酸衍生物 | |
| CN1642936A (zh) | 合成手性n-芳基哌嗪的方法 | |
| CN1922188A (zh) | 氯吡格雷之药学可接受的盐 | |
| CN1720228A (zh) | 制备利培酮及其中间体的方法 | |
| EA003609B1 (ru) | Способ получения замещенных 4-фенил-4-цианоциклогексановых кислот | |
| HK1043129A1 (en) | Method for the preparation of citalopram | |
| CN1178934C (zh) | 苯并呋喃衍生物 | |
| CN1313283A (zh) | 用于制备一类取代的二噁嗪的中间体 | |
| HK1070357B (en) | Process for the preparation of 5-substituted isobenzofurans | |
| CN1761668A (zh) | 具有抗肿瘤活性的喜树碱的7-亚氨基衍生物 | |
| AU2002325385A1 (en) | Process for the preparation of 5-substituted isobenzofurans | |
| EP2017271A1 (en) | Process for the preparation of escitalopram | |
| CN1326436A (zh) | 制备链烯基取代二肟醚衍生物的方法 | |
| CN101061121A (zh) | 生产苯并[с]菲啶衍生物的方法 | |
| CN109824537B (zh) | 一种n-(3-乙酰基-2-羟基苯基)乙酰胺的制备方法 | |
| CN1690038A (zh) | 生产2-苯甲酸基乙醛衍生物的方法 | |
| GB2376945A (en) | Citalopram preparation | |
| HK1071368A1 (en) | Method for the preparation of citalopram | |
| HK1071368B (en) | Method for the preparation of citalopram |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1070357 Country of ref document: HK |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |